Fisetin Inhibits Osteogenic Differentiation of Mesenchymal Stem Cells via the Inhibition of YAP
Mesenchymal stem cells (MSCs) are self-renewal and capable of differentiating to various functional cell types, including osteocytes, adipocytes, myoblasts, and chondrocytes. They are, therefore, regarded as a potential source for stem cell therapy. Fisetin is a bioactive flavonoid known as an activ...
Saved in:
Main Authors: | Chanchao Lorthongpanich (Author), Thanapon Charoenwongpaiboon (Author), Prapasri Supakun (Author), Methus Klaewkla (Author), Pakpoom Kheolamai (Author), Surapol Issaragrisil (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Endothelial Progenitor Cell Migration-Enhancing Factors in the Secretome of Placental-Derived Mesenchymal Stem Cells
by: Witchayaporn Kamprom, et al.
Published: (2016) -
The Effects of High Glucose on Adipogenic and Osteogenic Differentiation of Gestational Tissue-Derived MSCs
by: Weerawan Hankamolsiri, et al.
Published: (2016) -
Romidepsin Promotes Osteogenic and Adipocytic Differentiation of Human Mesenchymal Stem Cells through Inhibition of Histondeacetylase Activity
by: Dalia Ali, et al.
Published: (2018) -
CXCL13 Promotes Osteogenic Differentiation of Mesenchymal Stem Cells by Inhibiting miR-23a Expression
by: Feng Tian, et al.
Published: (2015) -
The Role of Flavonoids in the Osteogenic Differentiation of Mesenchymal Stem Cells
by: Jinli Zhang, et al.
Published: (2022)